Search

FDA developing new rules for artificial intelligence in medicine



The Food and Drug Administration announced Tuesday that it is developing a framework for regulating artificial intelligence products used in medicine that continually adapt based on new data.


The agency’s outgoing commissioner, Scott Gottlieb, released a white paper that sets forth the broad outlines of the FDA’s proposed approach to establishing greater oversight over this rapidly evolving segment of AI products.


Read more


source STAT

2 views

Recent Posts

See All

AbbotT, EUA, COVID-19 antigen test

Abbott gets EUA; COVID-19 antigen test #covid19test#antigen#covid19 Already in the antigen game - BD / Quidel / LumiraDx Abbott`s USP = scale + price scale - Abbott: 50 M / month by October - BD: 8 M

Contact
  • LinkedIn Social Icon

© 2019 IntMeDA